text:
End-to-end testing in the California Area, helping you ensure the electromagnetic compatibility of your equipment & subsystems to any version of MIL-STD 461 and MIL-STD 464.
With over 30 years of MIL-STD testing experience, we evaluate your equipment and subsystems to extreme electromagnetic conditions to ensure the electromagnetic compatibility (EMC) and mission readiness of your equipment.
Military contractors worldwide are sensitive to costs, design cycles, and performance. Equipment is vigorously challenged to meet stringent MIL-STD requirements to endure the harsh electrical conditions of today's battlefields. Our end-to-end testing capabilities, expert test technicians & engineers, and single-source testing solutions help you meet demanding contract deadlines.
Our streamlined testing process keeps lead time to a minimum and utilizes automation software to complete testing quickly and accurately.
View a full list of our MIL EMC testing capabilities here
- MIL-STD 461 Testing
- MIL-STD 464 Testing
- Conducted Emissions Testing
- Radiated Emissions Testing
- Conducted Susceptibility Testing
- Radiated Susceptibility Testing
- Power Quality Testing:
- Military Shielding Effectiveness testing:
MIL EMC Testing Capabilities
Our end-to-end EMC testing solutions evaluate your equipment to any electromagnetic condition; helping you meet critical reliability and performance standards that bring your equipment from development to end use faster and more cost-effectively.
MIL Environmental Simulation
Our end-to-end testing solutions evaluate your equipment to extreme environmental conditions, help you navigate stringent compliance standards, and validate environmental hardiness and mission readiness of your equipment for faster market access.
MIL Fiber Optics
We perform testing to the optical, mechanical, and environmental characteristics of your fiber optic products to validate safety, reliability, and performance.
COTS Testing
Comprehensive vibration and shock testing ensures your Commercial Off-the-Shelf (COTS) products repackaged for military use perform under harsh, mission critical applications.


text:
In a shocking political defeat guaranteed to upend Republican Party politics, House Majority Leader Eric Cantor of Virginia lost his primary election Tuesday to a tea party newcomer who hammered the No. 2 leader on immigration reform. It was the first downfall of a congressional leader in a generation.
Establishment Washington reeled from the moment the polls closed as Cantor, the ambitious leader with his sights on becoming the next House speaker, trailed Dave Brat, a local college professor who rustled for tea party support at a time when GOP leaders elsewhere have succeeded in halting the ascent of hard-right candidates.
In the end, Brat claimed an easy victory over the seven-term incumbent in the Richmond-area district.
"Serving as the 7th District congressman and having the privilege to be the majority leader has been one of the highest honors of my life," said Cantor, his wife, Diana, at his side.
The outcome was certain to not only ignite a leadership battle among the Republican majority in the House, but also to send a shudder though rank-and-file lawmakers who may become less willing to stray from tea party orthodoxy, particularly on the still looming debate over immigration reform.
"This stunning news could be the first shot in an all-out war between the establishment and tea party over leadership control," said GOP political strategist Ron Bonjean, a former top aide to Republican leadership.
The defeat of a congressional leader, especially one who is as prolific a fundraiser as Cantor, is almost unheard of. The majority leader's loss was the biggest electoral shock to the House since 1994, when Speaker Thomas Foley of Washington, a Democrat, was swept out of office in the GOP tidal wave that ushered in Republican control. More recently, Democratic Sen. Tom Daschle of South Dakota was ousted as Senate minority leader in 2004.
"This is the political version of the San Francisco earthquake," said Stuart Rothenberg, who publishes the Rothenberg Political Report, a nonpartisan analysis of elections. "It came out of nowhere."
But the signs were evident. Cantor's team had become increasingly concerned about the primary challenge from Brat, in part because the district had recently been redrawn and leaned further to the right.
A raucous political meeting earlier in the campaign season in the district made headlines as voters expressed their discontent over Cantor's leadership in the House, even after the majority leader had worked to curry favor with tea party lawmakers. The willingness of GOP leaders to negotiate an end to the government shutdown last fall, rather than hold out for a long-shot repeal of the president's healthcare program, and Cantor's interest in providing citizenship for young immigrants turned off hard-line Republicans both in Washington and at home.
Cantor, part of a new generation of GOP leaders who called themselves Young Guns, reacted in full force in recent weeks. The majority leader pummeled the airwaves, spending more than $5 million on the race, including a direct-mail piece that took a harder line against immigration reform than Cantor previously had advocated.
In many ways, however, the show of force gave more oxygen to the little-known Brat, who had few resources and almost no outside cash funding his underdog effort. To Cantor's millions, Brat raised only $200,000, and spent even less, according to the Center for Responsive Politics.
Among those who advocate changing the nation's immigration rules, Cantor's loss seems likely to dash all hope that the House will act on any legislation to provide a citizenship path for some immigrants -- as Cantor had once proposed.
Many had expected the chamber could turn to the issue once primary season had ended and lawmakers no longer had to worry about protecting their right flank.
Some, however, suggested that opportunities remain for Republicans to move forward on immigration. They took heart in the GOP primary success Tuesday of South Carolina Sen. Lindsey Graham, a GOP architect of immigration reform.
"Too bad Rep. Cantor didn't steal a page from Sen. Lindsey Graham, who leaned into the issue, was unapologetic about his principled stand and won his primary handily," said Frank Sharry, executive director of the immigration advocacy group America's Voice. "Elections are referendums on an incumbent's leadership ability. Graham won big. Cantor lost big."
As far as Cantor's future, it was not immediately clear what options, if any, he might pursue for the general election in November.
David Wasserman, a political analyst for the nonpartisan Cook Political Report, said Virginia's "sore loser" law prevents him from running as an independent in November. He may be able to mount a write-in bid, which would further complicate the general election race among Brat, Democrat Jack Trammel and several other candidates.
His departure also feeds into existing questions about party leadership on Capitol Hill, as some lawmakers wonder how long House Speaker John Boehner will seek to retain his post.
The No. 3 Republican in the House, Rep. Kevin McCarthy of Bakersfield, also part of the Young Guns leadership trio, with Cantor and Rep. Paul Ryan of Wisconsin, has made no secret of his own ambitions to move up the House ladder -- though the tea party's newfound momentum will all but certainly lead some of the chamber's hard-right leaders to make a play for a spot.

subset: commoncrawl


text:
Accessibility tools
Service tools
Language selector
Navigation path
Left navigation
Additional tools
European Commission - Press release
Europeans ready for 'active ageing', new survey says
Brussels, 13 January 2012 – To mark the start of the 2012 European Year of Active Ageing and Solidarity of Generations, the Commission presented today a new Eurobarometer survey showing that 71% of Europeans are aware that Europe's population is getting older, but only 42% are concerned about this development. This is in stark contrast with the perceptions of policy makers, who regard demographic ageing as a major challenge. For most citizens, people aged 55 years and older play a major role in key areas of society. Over 60% believe that we should be allowed to continue working after retirement age and one third says that they would like to work longer themselves. Surprisingly, people closer to retirement are more likely to share this view than the younger generation.
Lázló Andor, Commissioner for Employment, Social Affairs and Inclusion presented the survey saying: "Today's Eurobarometer survey shows that people are ready to remain active as they grow older. I am confident that the European year will act as a catalyst to mobilise citizens, stakeholders and decision-makers to take action to promote active ageing and to tackle the challenges of ageing in a positive way."
The Eurobarometer survey covers five areas: overall perceptions of age and older people; older people in the workplace; retirement and pensions; voluntary work and support for older people and an age-friendly environment.
The survey shows how definitions of 'young' and 'old' differ significantly across countries. In Malta, Portugal and Sweden, people under 37 years are considered young, whereas in Cyprus and Greece people are considered young up to the age of 50. On average, Europeans believe that we start being regarded as old just before 64 and are no longer considered young from the age of 41.8 years. Perceptions also vary with age and sex – women feel that old age begins slightly later than men (65.0 years versus 62.7 years respectively).
In terms of having a job, only one in three Europeans agrees with the idea that the official retirement age will have to be increased by 2030, even though this is now a clear policy priority in many Member States. However, there is strong support (61%) for the idea that people should be allowed to continue working once they have reached the official retirement age. 53% reject the idea of a compulsory retirement age, but there are huge differences across Member States.
Although the typical pensionable age is 65 years, the average exit age from the labour force in 2009 was about 61.5 years. 42% of Europeans believe that they will be capable of doing the work they are currently doing beyond the age of 65, while 17% expect that they will not be able to carry on in their current job until they are 60. One third of Europeans say that they would like to continue working after they reach retirement age, and the idea of combining a part-time job and a partial pension is more appealing than full retirement to almost two thirds of Europeans.
Active ageing is not just about employment. Around one quarter of Europeans (including those over 55) say they are engaged in voluntary work. In countries where there is less of a volunteering tradition, a higher proportion of people say that they have helped or provided support to other people outside their own household. 36% of Europeans over the age of 55 have provided such support. 15% of respondents over 55 take care of an older family member and 42% have done so in the past.
The European Year 2012 for Active Ageing and Solidarity between Generations seeks to raise awareness of the contribution of older people to society and to promote measures that create better opportunities for older people to remain active.
The European Year 2012 covers three dimensions of active ageing:
The European Year aims to encourage all policymakers and stakeholders to set themselves specific commitments related to active ageing and to take action to meet these goals. The commitments can be made public on the website of the European Year. Communication actions with general public, with stakeholders, decision makers and journalists will be organised at national and European level.
For more information:
Special Eurobarometer 378: Active Ageing (Report and Factsheets)
Comparative information on EU member states in MEMO/12/10
See also:
Website of the European Year of Active Ageing and Solidarity between Generations
European Innovation Partnership on Active and Healthy Ageing
Eurostat brochure - Active ageing and solidarity between generations – a statistical portrait of the European Union 2012
How to promote active ageing in Europe - EU support to local and regional actors
European Year for Active Ageing and Solidarity between Generations 2012
Side Bar


text:
If you registered on our previous website you will need to reset your password before you can access your account. Please follow the password reset instructions.
If you have forgotten your login details you can request a new password.
Register with us to easily access the content that is most useful to you.
Registration is open to all users. Members can access additional member-only content, book events and manage their preferences.


text:
Undergraduate Degrees, Majors and Concentrations
CHEM2215 - Chemistry II Lab
Summer 2019
This course emphasizes the general principles, theories and concepts of inorganic chemistry for students in engineering, environmental science and related fields. Topics covered include: Safety, solution chemistry, thermochemistry, reaction rates, equilibrium, acids and bases, complex ions, electrochemistry, density determination, stoichiometry, titration, spectroscopy, and periodic trends. Co-requisite: CHEM2210
1 Credits
Schedule Book for All Active and Available Future Terms, Course starting with CHEM2215
No Courses Found


text:
The easiest way to share files with your friends.
Sign up for an account and start sharing now.
1.Visit Crate.
Visit Crate and sign on. You'll be presented with a list of crates. A crate holds one or more files. Select one of the crates.
2.Upload your files.
Drag-and-drop all of the files you want to your heart's content. They'll be stored on the cloud, accessible from anywhere.
3.Share the link!
Now you can share away, either a whole crate or an individual file, your choice. We provide a short URL for ease-of-use.


text:
Downloads: 50,560
Last Activity: Today 6:36 PM
Puffin McMuffin
staff: administrator
About Me
Do not use my meshes as a base! If you want to use them, please PM me first!
Exceptions are my conversions. Use them for whatever you wanna use them for!
If you want to use any custom scripts/adjust them, please message me.
Do not reupload them on different sites! Thanks!
That's all! ^-^
Top Download
Camisole dresses for your sims! Whether your sim likes to wear nightgowns or just something for everyday, this set will work pretty well for any sim! :)
16th Aug 2017 at 7:41pm in » Everyday21,874
Personal Picks
A cottage for introverted plant nerd sims!
17th Mar 2019 at 9:55pm in » Residential5,505
Some modern-y pet beds to get rid of EA's pillow-y beds... because pets deserve love too!
27th Mar 2018 at 4:49pm in » Pet Objects27,908
A small little lot for your outdoors sims or witches!
21st May 2017 at 10:57pm in » Residential18,849
Lyralei has 10 downloads in the following areas of our download section:
7th Sep 2019 at 4:03pm
17th Mar 2019 at 9:55pm
26th Dec 2018 at 12:08pm
Oh My, Granny! - TS3/2 to TS4...
23rd Sep 2018 at 1:59pm
Pet beds of the midcentury! +...
27th Mar 2018 at 4:49pm
Christina Fiona Mansion - 4 bedr,...
20th Aug 2017 at 8:27pm
16th Aug 2017 at 7:41pm
Cosmic Harmony - 1 br, 1 ba + CC
21st May 2017 at 10:57pm
The sims 2 to the sims 3 Bug house...
9th Apr 2017 at 10:39pm
MTS 2017 Calendar for The sims 4
20th Jan 2017 at 11:07pm
- Do not upload to the Exchange.
- You may include with recolours.
- You may re-use my textures for unrelated projects.
- Additionally:
- You may recolour using my textures.
- Please give credit with a link when using my work.
- Ask me first before modifying/using.
- Let me know if you use my work.
- Onoz!! Zmobies!!!
Lyralei is not a member of any public groups
My Tumblr | My Downloads | My Stories | My Tutorials (Tumblr) | My Tutorials (YouTube)
Sims 1 Games Purchased: Sims 1, Livin' Large, House Party, Hot Date, Vacation, Unleashed, Superstar, Making Magic Location: Land of the cheese! Tumblr name: greenplumbboblover
Games owned: The Sims 2: The Sims 3: The Sims 4:


text:
Just the right service management fit
for the small and midsized business
BMC FootPrints
IT service management for mid-size organizations
BMC FootPrints integrates IT service and asset management for end-to-end business services, and it's easy to install, use, and support. With configurable capabilities that streamline service delivery, FootPrints improves customer satisfaction and IT's reputation with your business users.
- Improve efficiencies by simplifying and automating routine tasks.
- Reduce total cost of ownership by enabling users to resolve common issues on their own.
- Improve satisfaction with an easy-to-use interface and mobile capabilities.
- Maintain compliance as you document, record, and centralize IT tasks.
- Create business value and reduce risk with better visibility into the IT environment.
IT service and asset management in one integrated solution
FootPrints Service Core improves user satisfaction and increases productivity to help your IT department deliver more value to your business.
Incident and Problem Management
Easily initiate, route, track, and manage incidents—no programming required.
Knowledge Management
Create a searchable inventory of common issues and their resolutions.
Executive Dashboard And Business Analytics
Increase uptime and compliance by instantly monitoring key metrics, including adherence to service level agreements (SLAs).
Visualization And Reporting
Easily and quickly automate processes, solve issues, and communicate with the business by using tools like the drag-and-drop visual workflow builder, impact analysis, and real-time report building.
Mobile Access
Conveniently access a full range of functions from any device.
Take a closer look
- Minimize risk by automating change management procedures.
- Improve cross-functional efficiencies.
- Accelerate configuration, compliance, and problem solving.
- Enable customers to select services according to their business needs, 24x7.
- Save time troubleshooting known issues.
- Reduce training requirements for new IT staff.
Design the best FootPrints solution for your business
Supplement your FootPrints Service Core solution with optional capabilities designed to have real-world impact on how your business functions.
Asset discovery and inventory
Automate complex inventory tracking and receive complete, accurate asset intelligence.
Remote control
Securely manage routine desktop management tasks without leaving your desk.
OS and application deployment
Quickly and reliably install or configure software without disrupting the user.
Patch management
Centrally manage, deploy, and report on patches across diverse IT environments.
Compliance management
Quickly and easily provide records of compliance levels.
Power management
Reduce energy bills and lessen your environmental impact.
Migration management
Easily move desktop layouts, metadata, drive mappings, customized settings, and file/folder structures.
Complete your solution with client management
FootPrints Asset Core (Client Management)
BMC FootPrints Asset Core automates management of your IT assets to help control costs, maintain compliance, and reduce financial risks.


text:
Marketing is undoubtedly one of the most crucial success factors for new online businesses and should be a primary emphasis early on. But if you only focus on traditional traffic generation strategies like link building you're missing out on lots of potential customers.
The following strategies can easily help you increase your website's traffic - even double it - without having to do an ounce of marketing. Here's how:
1. Add Long-Tail Variations to Your Pages
It's easy to focus on short, high-volume terms because they are easier to identify and research. But in reality, 80% to 90% of the traffic you're likely to receive will be from "long-tail" queries with three, four or five-plus words.
Long-tail keywords are easier to rank for and usually convert at a much higher rate than shorter, more generic terms. Here's how you can maximize your exposure to long-tail variations and increase your traffic:
Identify Long-Tail Modifiers
Let's pretend we sell the Logitech C310 webcam and wanted to optimize our page to rank for as many searches as possible. We'd visit our old friend the Google Keyword Tool and make note of all the long-tail variations. We'd also want to look at the bottom of the search results where Google lists related searches. The related searches for "Logitech C310" look like this:
Work these Modifiers into Your Page Copy
Because our Logitech C310 page is (hopefully) somewhat optimized for the term "Logitech C310", we don't need to insert each long-tail search phrase verbatim into the page. Instead, we want to work the unique variations at the end of "Logitech C310" into our copy to allow the possibility that we can rank for it.
Revisiting the related searches from above, we'd want to make sure the words boxed in red below appeared on our page:
We'd want to ensure our page included the words "Skype" and "Mac", as well as discussed the differences between the C525 model using the "vs c525" phrase. With all of these newly included modifiers incorporated into the copy, our page has the potential to rank for a wider range of queries.
Not all of the modifiers we uncovered will be applicable. Branded keywords - like "best buy" above - won't be useful, and we would likely have a number of modifiers already incorporated. However, more often than not, we'll uncover a handful of long-tail gems to help increase potential ranking opportunities and ultimately boost our traffic.
2. Stand Out with Rich Snippets
Rich snippets are search listings that include information regarding a product's price, availability and review count. They're useful for learning more about the particular product and/or site at a glance from the search results page without having to visit it.
Rich snippets are incredibly powerful because they can increase the number of people that click on your page by up to 30%. That's a huge boost for something that can usually be implemented relatively painlessly! Compare that to increasing your marketing or ad-spending budget by 30% and you'll see why it's so powerful.
The process for setting up or enabling rich snippets will vary based on your platform, so you may need to do some research to get it implemented. Once you think everything is setup properly, you can use Google's Rich Snippets Testing Tool to make sure there won't be any display problems. Rich snippets can take some time to appear in the search listings, so don't worry if you don't see them right away.
Authorship and Video Thumbnails
Product-based rich snippets will likely be the most applicable for many merchants, but there's also two other types of enhanced listings to know about: Google Authorship and video thumbnails.
With authorship markup you can tell Google which content you've written and your picture will appear alongside the listing for that piece. Just like the name implies, video thumbnails are a thumbnails of a page's embedded video that appears alongside a page listing. Just like product-based rich snippets, both of these have also proven to dramatically increase the click through rate of the associated pages.
When should you use each type of enhanced markup? That will vary based on your content, products and goals. Google Authorship markup could be a great choice for enhancing a store's blog posts in the search results, while video thumbnails could potentially help video-rich educational pages stand out.
We're now even seeing multiple mark-up mediums combined in one listing, as seen below:
Setting up Google Authorship is fairly simple assuming you have a Google Plus profile. For more information, see these guides by KISSMetrics and 312 Digital.
To get video thumbnails to appear, you'll need to create a video sitemap for Google. You can do this manually via your Webmaster Tools account, and some video hosting services like Wistia (I love these guys!) will do it automatically for you. For more details on video SEO and thumbnails, see this video from Wistia.
3. Write Titles and Descriptions People Can't Resist
The meta title and meta description are attributes that determine how your page appears in the search results - and they're immensely important. Write a compelling title and interesting description and you'll stand out to searches. Alternatively, if your copy is boring and doesn't offer any compelling reason to click, you'll get much less traffic.
In the search results below, I've tried to make the homepage for my trolling motor store stand out by highlighting:
- That we focus exclusively on high-end trolling motors
- We offer free shipping
- We don't charge sales tax
Despite competing against some big competitors, I'd bet our listings receives a higher click-through rate than the other pages, especially given many of them aren't very appealing from a sales and copywriting perspective.
When writing meta titles and descriptions, you need to approach think like you're writing an advertisement - because you are! Highlight your expertise, unique selling proposition, and why the customer will benefit shopping with you.
You also want to keep SEO and keyword optimization in mind, but don't go overboard. Include your primary keyword(s) at least once in the title and description, ensuring they flow naturally with your copy. But when in doubt, prioritize readability over SEO.
Revamping underwhelming titles and descriptions with compelling copy can have a massive and almost overnight impact on the traffic you receive.
4. Leverage Your Internal Links
Getting links from other sites is obviously an important and well-known technique. Far fewer people understand how much influence your own site's structure and internal links have over your rankings. Need to give a particular page a rankings boost? Linking to it from existing high authority pages on your domain can pass authority and help the target page to rank better.
Here's what you can do:
- Make a list of high-value target pages you'd like to rank better.
- Identify the pages on your website that currently have the most authority and "SEO juice."
- Add a link from your authority page(s) to your target page(s).
- Incorporate the link naturally on the authority page using anchor text related to the keyword you'd like the target page to rank for.
A site's homepage will usually be the most authoritative page on a domain, so it's an obvious choice for an authority page to link from. To find other internal authority pages, use Open Site Explorer to search for internal links, and then sort in descending order by Page Authority so the most authoritative internal pages rise to the top.
This is just the tip of the iceberg when it comes to what you can do with internal linking. For more information on internal linking see these articles from HubSpot and SEOMoz.
The Power Of Optimization
It could take years to double your traffic if you relied solely on increasing the number of backlinks your site had. Using the techniques discussed above, it's possible to drastically increase your traffic by making smart adjustments to your existing site - and in significantly less time.
What would you do with twice the number of customers?
By Andrew Youderian of eCommerceFuel.com.
Sourced From: Shopify.com
Read more: http://www.shopify.com/blog/7655755-how-to-double-your-traffic-without-any-marketing#ixzz2SvDhd6H7


text:
Undergraduate Degrees, Majors and Concentrations
THEA3310 - Voice and Diction
Summer 2019
Students in this course will develop the skills necessary to be easily heard and immediately understood in any performance situation: theatrical, speech, or business. Students will adhere to acceptable practices of conversational English and overcome regional inflections and idiosyncratic vocal habits. The students will increase their vocal flexibility, attention to nuance, and articulation precision by applying a scoring technique for Spoken english drawn from The International Phonetic Alphabet.
3 Credits
Schedule Book for All Active and Available Future Terms, Course starting with THEA3310
No Courses Found


text:
Greetings everyone. The Oak Island Tourism Society is indeed gone but their efforts will never be forgotten. When it folded, all assets of the OITS were transferred to the Chester Municipal Heritage Society and over the past year and a half, we have been steadily building a very well received Oak Island display in the Chester Train Station at 20 Smith Road. I invite you to have a look at this web site to learn more about the display and all that goes with it. Also use the links to see what other initiatives the CMHS has been working so hard on.
http://chesterbound.com/Oak%20Island/ex ... Island.htm
I hope if you are ever in this area of Nova Scotia, you take the time to visit the display appropriately called Explore Oak Island Display. Best part is, as you walk in the door you will see that it is dedicated to the founder of the OITS John Chattaway and members of the Oak Island Tourism Society.


text:
Halos eyeing brighter days after gloomy start
KANSAS CITY -- It is not difficult to see a brighter future for the Los Angeles Angels of Anaheim.
The hard part with this club came as recently as one week ago, looking at the Angels' 15-27 ledger and trying to ascertain how all that talent came to that sort of record. Well, the pitching might have had quite a bit to do with it.View Full Game Coverage
KANSAS CITY -- It is not difficult to see a brighter future for the Los Angeles Angels of Anaheim.
The hard part with this club came as recently as one week ago, looking at the Angels' 15-27 ledger and trying to ascertain how all that talent came to that sort of record. Well, the pitching might have had quite a bit to do with it.View Full Game Coverage
Now, the outlook is not nearly as grim. The Angels, at 21-27, still have uphill as their next direction. But they also are in their best stretch of the season, their winning streak stretched to six with Friday night's 5-2 victory over the Kansas City Royals.
Every portion of the Angels' game has picked up during this streak. Their starters have delivered five fine performances. Their bullpen has held leads. Their hitters have produced 47 runs over six games.
All right, all of the Angels' opponents in this stretch -- the White Sox, Mariners and Royals -- are now playing under .500 baseball. You cannot blame the Angels for this. They are just playing the schedule. They are not drawing up the schedule.
But the Angels' play has picked up, and there is further reason for optimism. Rotation ace Jered Weaver, coming back from a fractured arm, had a successful bullpen session on Friday. If another bullpen session on Sunday goes well enough, manager Mike Scioscia said that Weaver could rejoin the Angels next week.
There aren't many clubs that could withstand getting only two starts out of their ace over the first two months of the season. The Angels apparently aren't one of those clubs.
But the theme here is that, for the Angels, the worst is over. Leading out of that, the next concept would be that the best is yet to come.
There have been some impressive offensive displays during this stretch; two 12-run games and then a four-home run game in the opener of this series on Thursday night. But for Scioscia's view of what needs to happen for this club to succeed over the long term, the pitching has been even more encouraging.
"To be honest with you, the quality starts is doing a lot more for our outlook, and holding leads, is doing wonders for our outlook," Scioscia said. "I think we're very comfortable with the fact that our offense is going to be there for us. Hopefully, we'll start to get a little more depth as guys start to come back from being banged up.
"Our ability to hold leads will improve and the depth of our rotation will be there. That's what this thing is all about, is the ability to get out there with someone on the mound every night with someone who is going to give you a chance to win. And when you do get a lead, some guys in the bullpen to hold those leads.
"We're developing bullpen depth. I don't' think we're where we'll end up to be, with Ryan Madson and Kevin Jepsen, who we anticipate helping us. But Sean Burnett was huge for us, and that was indicative [Thursday] night, coming in to get a ground ball [double play] and get out of an inning. There's a lot of games when Sean wasn't available or was on the DL, that we knew there was a role for him that would come up in a key spot in a game."
Jason Vargas has won two of the games during the streak, including Friday night's contest. The lefty went 7 1/3 efficient innings, before turning the game over to Garrett Richards, who got the necessary five outs for his first save.
The thought is that if the Angels' pitching staff can keep this club in games, the offense will produce enough to win. There have been some performances below career norms in the Angels' lineup, but this remains a diverse offense, with speed and power and the proven ability to generate runs in several ways.
When Scioscia was asked if this level of play was sustainable, he smiled and responded: "I sure as hell hope it is.
"Hopefully, we're going to keep building momentum and moving in the right direction. But I think this is much more in line with the team we projected, the way we've seen them play the last week."
That is the idea. The team the Angels projected would be an exceptionally good team, maybe even a championship team. When this club went 15-27, it seemed to be a completely different team.
This recent 6-0 club, however, looks much more like Plan A. The sample size is small, but both the direction and the performance are greatly encouraging.
Mike Bauman is a national columnist for MLB.com.


text:
Staying safe and well
Hot Topics
The University has a legal obligation to ensure a safe and healthy workplace for its employees, students, visitors and other users. Morally the University is keen to ensure all users of its sites remain safe and well.
Financially it recognises that good health & safety is key in maintaining high productivity, reducing the likelihood of accidents and helping to foster a positive safety culture. The University endeavours to promote this positive health and safety stance through the:
Provision of information, guidance and support
Comprehensive assessment and management of risk
Training, including in-house and self-learning
Competent professional advice
Pro-active and reactive monitoring
Details of how the University will manage its commitment is outlined within the Health and Safety Policy - Statement of Intent and other hazard specific policies.


text:
Toshl API - Changelog
Toshl is a personal spending tracker that helps users monitor what they're spending their money on. Expenses can be entered in any currency through mobile apps or the Toshl website. Users can create budgets for specific categories of spending and get reminders for recurring monthly expenses. Users can view summaries of their spending using fun graphs and visualizations, and they can also export financial calculations in CSV format.


text:
You have no items in your shopping cart.
The exquisite Opera collection evokes a sense of modern elegance with a hand woven touch. Beautifully stylish, with curvaceous high backs and sweeping triple laminated rattan arms for added comfort. You have the added facility of a shelf rack on both the coffee and lamp tables for your newspapers and magazines.
Available options: 3 Seater Sofa, 2 Seater Sofa, Chair, Coffee Table, Lamp Table and Footstool.
Choose from the following fabrics in the dropdown above, quality grades A-D
About Desser
Founded in 1919, this fourth generation family run business is as passionate as ever on quality, service and style. Customer care and design excellence is at the forefront of the business with a vision to provide elegant and contemporary cane furniture to suit all living rooms, kitchens and conservatories.
As a fourth generation family run business Desser continues to be committed to offering an ever developing wide range of rattan furniture to suit all tastes, plus a comprehensive and complimentary range of fabrics including the innovative Aquaclean fabric. Crafted to the highest standards, assembled in the UK and with all cushions made in-house, Desser furniture is not only versatile but also reliable and durable. All frames are supported with Pirelli webbing and have a 12 month guarantee. All ranges feature Dacron wrapped base cushions for both shape retention and softness.
Cane furniture is hand made from natural products and no two pieces are exactly the same which is all part of its natural beauty. For more information on Desser, please see this page.
Caring for your Desser Furniture
A Desser cane suite has been individually made by hand using the highest quality materials to the most exacting standards of design and finish. As a general rule, cane furniture should be kept in a dry environment and not left under direct sunlight for prolonged periods. If the furniture is in a conservatory then we recommend that you move it around occasionally so that different parts are exposed to the sun. Where possible, blinds should be used to protect the furniture. If properly cared for all Desser products can last a lifetime.
The cane frames should be cleaned by gently wiping with a soft, very slightly damp cloth and the use of a dry paintbrush to regularly dust between grooves is a good idea. Alternatively a vacuum cleaner with a small brush attachment can be used.
An occasional spray of any good furniture polish will keep the cane looking its best - avoid applying benzene, thinners, abrasive creams or other potentially harmful chemicals.
Cushions should be turned as often as possible so that any fading caused by direct sunlight is evenly spread.
You may also be interested in the following product(s)
Desser Opera Natural 3 Seater Suite and Cushions
Our Price:
Desser Opera Natural Sofa and Cushions
Our Price:
Desser Opera Natural Suite and Cushions
Our Price:
Desser Opera Natural Footstool and Cushions
Our Price:
Desser Opera Natural 3 Seater Sofa and Cushions
Our Price:


text:
Sony Ericsson Xperia PLAY 4G Pictures
This is AT&T's version of the Sony Ericsson Xperia PLAY which is the first PlayStation Certified device and the first specialized Android gaming phone to hit the market. It features a slide-out gamepad, 4" LCD screen and a second generation 1GHz Snapdragon chipset. There is a dedicated section on Android Market for it, which will list titles written specifically for the Sony Ericsson Xperia Play, or ported over from other mobile devices.


text:
The Law School's Academic Careers Committee offers alumni practice job talks, helps schedule them for workshops at other schools, organizes faculty recommenders, and centralizes the Law School's marketing of the candidate to other schools. The giving of advice is not limited to members of the committee: Other faculty provide advice to applicants (and applicants have discussions with their references on the faculty), but the committee is available as a resource and helps to make sure that applicants receive the advice they need. The contact address for the committee is: firstname.lastname@example.com.
In addition to this personalized guidance, there are a number of websites that offer general advice to prospective legal academics about the law teaching market. They include:
Brad Wendel's site:
Eric Goldman's Resource List:
Association of American Law Schools Faculty Recruitment Page: http://www.aals.org/frs/
School websites on teaching:


text:
MSN - Master of Science in Nursing
Program Advantages:
- Designed to be completed in less than 2 years while working full-time as a Registered Nurse
- Classes are small enough to allow instructor/student individual attention for professional growth
- Hybrid courses that provide both online and valuable face-to-face interaction with faculty
- Classes meet face-to-face for just ONE HALF-DAY PER MONTH for the entire program
- Faculty who are committed to students' learning with current, relevant expertise in nursing practice
- A diverse population of nurses who bring unique, "real world" experiences and knowledge to the classroom
- Strong collaboration and partnerships with regional health care providers to facilitate clinical experiences that are relevant to a Registered Nurse student
- Easy online access to full library services and reference material
- Numerous scholarships, grants, and "service-cancellable loans" available to Registered Nurses enrolled in the MSN program
The mission of the Master of Science in Nursing (MSN) program at Thomas University is to prepare nurses who are reflective and critical practitioners of the art and science of nursing; are caring, culturally competent, and politically aware; and who practice within a legal and ethical framework in the advanced roles of leader, advocate, educator, and researcher. The graduate will be an effective communicator, a competent scholar, and a professional role model. Graduates of the MSN program will be equipped with the knowledge, competencies, and values to assume roles as nursing leaders or educators in current and future health care or academic settings.
The MSN program is designed to allow students to maintain an active nursing practice while attending classes on campus one half-day per month. Courses are offered through a "hybrid" learning model, using a combination of a traditional classroom environment and online instruction. In addition, class sizes are intentionally small to allow for dynamic interaction between students and faculty. Internship hours are arranged at times and locations convenient to students and preceptors.
For more information, e-mail TU Admissions or call 229-227-6925.


text:
Inventory Unit Detail
2019 Ferris F320Z 5901711 - 61" 29.5HP Kawasaki®
Call for Price
If you demand power, performance and dependability all at a great value, look no further than the Ferris® F320Z. This top-of-the-line Fleet Series model comes equipped with a premium high-back adjustable suspension seat and heavy-duty components, such as Hercules™ II cast-iron spindles. Large 26" drive tires allow for greater traction, smoother ride and improved curb climbing performance. Choose between multiple engine options: a Vanguard™ BIG BLOCK™ and a Vanguard™ BIG BLOCK™ EFI both offering a 500 hour oil change interval with the new Oil Guard System or a Kawasaki® FX850V EFI, all with a 3-year limited manufacturer's warranty†
- 500 Hour Oil Change (Select Models): Vanguard™ Engines with Oil Guard System reduce maintenance time and costs by up to 60%.**
- Powerful Engine: For the most challenging applications, this BIG BLOCK™ EFI Engine has been expertly engineered to deliver the dependability to get more done in less time.
- Hercules™ II Spindles: Hercules™ II Spindles industrial 10" dia. cast-iron spindle assembly with 1 3/16" dia. shaft and greaseable double row angular contact ball bearings, which can be greased through the convenient top access grease fitting.
- iCD™ Cutting System: The iCD™ Cutting System was engineered to produce the best possible cut in a multitude of conditions.
- Commercial Transmission: Dual, commercial Hydro-Gear® ZT-5400 Powertrain® Transaxles deliver unmatched power and durability.
- Accessibility: Quick removal of the floor pan provides convenient access to the top of the deck for easy cleaning and service.
- Premium High-Back Suspension Seat: Suspension seat with reclining back and lumbar support for optimal comfort.
- Foot-Operated Deck Lift: Foot-operated deck lift, with adjustable pedal, can change cut height in 1/4" increments from 1.5"- 5".
- Traction: Large 26" drive tires allow for greater traction, smoother ride and improved curb climbing performance and faster cutting speeds.
- Ride-On Mower Warranties†: 4-Year limited warranty (48 months) or 500 hours, whichever occurs first. Unlimited hours during the first 2 years (24 months). Belts, tires, brake pads, battery, blades: 90 days.
- Engine Brand: Kawasaki® FX850V EFI
- Displacement (cc): 852
- Cylinders: 2
- Fuel Tank Capacity (gal): 11
- Cutting Height (in): 1.5 - 5
- Deck Construction: iCD™ Cutting System
- Transmission: Dual commercial Hydro-Gear® ZT-5400 Powertrain® Transaxles with 9" cooling fans
- Caster Tires (in): 13 x 6.5-6 Flat-free
- Ground Speed-Fwd (mph): 0-12
- Overall Length (in): 81
- Dry Weight (lbs): 1405
- Instrumentation/Hour Meter: Fuel level gauge in each tank, hour meter
- Controls / Safety Group: Seat activated engine kill, clutch safety switch, neutral and parking brake safety circuit, adjustable twin steering controls
- Warranty (Engine) †: 3-Year limited manufacturer's warranty
- Engine Power Rating *: 29.5 gross hp
- PTO: Electric
- Starter: Electric
- Cutting Width (in): 61
- Spindles: Hercules™ II Spindles
- Suspension: N/A
- Drive Axles (in): 1.375 Tapered
- Drive Tires (in): 26 x 12-12
- Ground Speed-Rev (mph): 0-6
- Overall Width (in) Deflector Down/Deflector Up: 76 / 63
- Seat Package: Premium suspension high-back seat with adjustable arm rests, adjustable lumbar and back recline
- Certified Roll-over Protection System: Standard, 165° foldable
- Parking Brake / Safety Circuit: Internal transaxles
- Warranty (Balance of Machine) †: 4-Year limited warranty (48 months) or 500 hours, whichever occurs first. Unlimited hours during the first 2 years (24 months). Coverage on other components varies, please see operator's manual for complete details.
** Cost savings based on oil maintenance with 100 hour interval versus Oil Guard System 500 hour service interval.† See operator's manual or dealer for complete warranty details. Refer to engine operator's manual for engine warranty.
- Engine Manufacturer
- Kawasaki®
- Horse Power
- 29.5 hp
- Engine Type
- Displacement
- 852cc
- Transmission
- Dual commercial Hydro-Gear® ZT-5400 Powertrain® Transaxles with 9 in. cooling fans
- Wheel Size
- 26 x 12-12 in.
- Fuel Capacity
- 11 gal.
- Deck Size
- 61 in.


text:
Big Words Are Fading, But Many People Still Love Them
Can those who enjoy sesquipedalian words, and those who find them annoying, learn to connect
I love big words. It started when I was a kid and first heard "supercalifragilisticexpialidocious." ("Something to say when you don't know what to say," according to the movie "Mary Poppins.")
I quickly moved on to real words: "Ebullient," "innocuous" and "malodorous" were some of my favorites. If I came across a word I didn't know in a book, I looked it up. I made flashcards to help myself remember the ones I particularly liked. Now I'm worried that big words—the...


text:
Sign In
or Join Now!
Posted on Workbench question...
home | projects | blog
6 posts in 3609 days
#1 posted 12-24-2009 10:34 PM
I use veneer core. I try to avoid MDF as much as possible but I have used it in the past :)
Go to Pulse page »
©2019 Verticalscope Inc. All Rights Reserved. |
Terms of Service
| Copyright
| Privacy Policy
DISCLAIMER: Any posts on LJ are posted by individuals acting in their own right and do not necessarily reflect the views of LJ. LJ will not be held liable for the actions of any user.
Latest Projects |
Latest Blog Entries |
Latest Forum Topics


text:
ABSTRACT: The 10-year survival rate for patients with metastatic melanoma is less than 10%. Although surgery and radiation therapy have a role in the treatment of metastatic disease, systemic therapy is the mainstay of treatment for most patients. Single-agent chemotherapy is well tolerated but is associated with response rates of only 5% to 20%. Combination chemotherapy and biochemotherapy may improve objective response rates but do not extend survival and are associated with greater toxicity. Immunotherapeutic approaches such as high-dose interleukin-2 are associated with durable responses in a small percentage of patients. In this article, we review the treatments for metastatic melanoma including promising investigational approaches.
Metastatic melanoma continues to be a challenging disease to treat, with an estimated 8,420 related deaths in the United States in 2008.[1] The 10- year survival rate for patients with metastatic melanoma is less than 10%.[2] More than 3 decades after its initial approval by the US Food and Drug Administration (FDA) in 1975, dacarbazine continues to be the standard of care for most patients with this disease. High-dose interleukin-2 (HD IL-2 [Proleukin]), approved by the FDA in 1998 for metastatic melanoma, benefits a small subset of patients. Attempts to improve upon the survival of patients with metastatic disease have met with failure, and the need for successful new therapies for metastatic melanoma cannot be overemphasized. However, our understanding of the biology of this disease is steadily increasing, and many promising therapeutic approaches are currently under investigation. We discuss the various systemic therapeutic approaches to the treatment of metastatic melanoma below.
Prognostic Factors for Metastatic Melanoma
Many factors have been proposed to influence the prognosis in patients with metastatic melanoma. The impact of the initial site of metastasis on survival was studied in a multivariate analysis of 1,521 patients with stage IV melanoma. Three groups of patients were identified: those with cutaneous, nodal, or gastrointestinal tract metastases; those with isolated pulmonary metastases; and those with liver, brain, or bone metastases.[3] The median survivals in these three groups were 12.5, 8.3, and 4.4 months, respectively. The 5-year actuarial survivals were 14%, 4%, and 3%, respectively. In addition to the site of disease, the presence of an elevated serum lactate dehydrogenase (LDH) has also been associated with poor prognosis.[4,5] The 2002 American Joint Committee on Cancer (AJCC) staging system of cutaneous melanoma classifies patients with metastatic disease into three categories based on the site of metastases and serum LDH level (see Table 1).[2]
Other factors that have been associated with shorter survival include older age, poor performance status, male sex, greater number of metastatic sites, shorter disease-free interval, hypoalbuminemia, pretreatment neutrophilia, and leukocytosis.[3-7] The identification of valid prognostic factors is important to the design and interpretation of clinical trials in metastatic melanoma.
Roles of Surgery, Radiation Therapy, and Systemic Therapy
The presence of distant metastases usually reflects hematogenous dissemination of melanoma cells. The cornerstone of treatment for metastatic melanoma is systemic therapy to address the subclinical sites of metastases as well. Locoregional treatment modalities such as surgery or radiation are usually reserved for palliation of symptoms due to local tumor growth.
Resection of distant metastases may also be considered for selected patients in whom a survival benefit might be expected with surgical rather than medical treatment. Surgery may potentially improve outcomes in patients with fully resectable oligometastatic disease.
In a report of 144 patients who underwent surgical resection of nonregional metastatic melanoma, the overall 5- and 10-year survival rates were 20% and 14%, respectively.[8] Patients with a solitary metastasis confined to the subcutaneous, nonregional lymph nodes or lung were most likely to benefit from aggressive surgical intervention. In another series of 77 patients undergoing surgical resection of metastatic disease, the overall 5-year survival rate was 10%.[9] Patients with solitary lesions had a 5-year survival rate of 12%, compared with 0% for patients with multiple lesions. Patients with complete resection had a 5-year survival rate of 15%, compared with 4% for patients with incomplete resection. Patients with complete resection of solitary lesions had a 5-year survival of 18%. However, the retrospective and nonrandomized nature of these reports makes it difficult to distinguish the true benefit of surgical intervention from the differences in natural history of disease.
Radiation Therapy
Melanoma is considered a relatively radioresistant tumor, but patients may derive clinical benefit from radiation of symptomatic metastases. Radiation therapy is usually used as an adjunct to the use of systemic therapy. Radiation therapy (whole-brain irradiation and/or stereotactic radiosurgery) is especially useful in patients with central nervous system (CNS) metastases, as most systemic therapies have limited penetration into the CNS.
Systemic Therapy
Systemic therapy is the mainstay of therapy for most patients with stage IV melanoma. Systemic therapies include cytotoxic chemotherapy, immunotherapy, or a combination approach such as biochemotherapy. In addition, many novel therapies are currently under investigation.
Cytotoxic Chemotherapy
Cytotoxic chemotherapy has been used for the treatment of metastatic melanoma for over 3 decades. Chemotherapeutic agents with modest antitumor efficacy in metastatic melanoma include alkylating agents (dacarbazine, temozolomide [Temodar], nitrosoureas), the platinum analogs, and the microtubular toxins. These agents have been used alone or in combination.
Single-Agent Chemotherapy
• Dacarbazine—An alkylating agent, dacarbazine (5-[3,3-dimethyl-1- triazenyl]-imidazole-4-carboxamide, or DTIC) is the only chemotherapeutic agent approved by the FDA for treatment of melanoma. A pooled analysis of 23 randomized, controlled trials showed that the objective response rate (ORR) for 1,390 patients receiving dacarbazine alone was 15.3%. The majority of these responses were partial (11.2% partial responses [PR], 4.2 % complete responses [CR]).[10] Responses are seldom durable, and fewer than 2% of patients treated with dacarbazine alone are alive at 6 years.[11] Since dacarbazine monotherapy has not been investigated in a placebo-controlled trial, there is insufficient evidence to suggest an overall survival benefit with dacarbazine. The primary purpose of dacarbazine therapy for metastatic melanoma is palliation.
Dacarbazine is typically administered intravenously at a dose of 150 to 200 mg/m2/d for 5 days or at a single dose of 800 to 1,000 mg/m2, with doses repeated every 3 to 4 weeks. The latter schedule is more convenient and is well tolerated by most patients. Common toxicities include mild nausea and vomiting, myelosuppression, and fatigue, and most patients are able to maintain their baseline quality of life.
Despite its modest efficacy and lack of data for survival benefit, dacarbazine continues to be the "standard treatment" of metastatic melanoma. No other therapy has yet been shown to have a significant survival benefit over dacarbazine.
• Temozolomide—An orally administered analog of dacarbazine, temozolomide has been extensively tested in melanoma. Like dacarbazine, temozolomide is converted to the active alkylating metabolite MTIC (3-methyl-[triazen-1-yl]-imidazole- 4-carboxamide). Unlike dacarbazine, however, this conversion is spontaneous, nonenzymatic, and occurs at a physiologic pH in all tissues to which the drug is distributed. Besides having excellent oral bioavailability, temozolomide penetrates into the CNS and may potentially prevent or treat melanoma brain metastases. These attractive features have prompted extensive investigation of temozolomide in metastatic melanoma.
A phase III trial randomized 305 patients to receive temozolomide (200 mg/m2/d orally for 5 days every 4 weeks) vs dacarbazine (250 mg/ m2/ d intravenously for 5 days every 3 weeks).[12] The median overall survival (OS) and ORR for patients treated with temozolomide (7.7 months and 14%, respectively) were not statistically different from those treated with dacarbazine (6.4 months and 12%, respectively).
The results of another multicenter phase III trial that randomized 859 patients to receive dacarbazine vs an extended dosing schedule of temozolomide (150 mg/m2/d on 7 consecutive days every 14 days) were recently reported.[13] The investigators found no significant differences between dacarbazine and temozolomide in ORR (10% and 14%, respectively), progression-free survival (PFS, 2.1 and 2.3 months, respectively), or OS (9.3 and 9.1 months, respectively).
Temozolomide has also been substituted for dacarbazine in various combination chemotherapy or biochemotherapy regimens in an effort to reduce the high rate of isolated CNS relapse in patients exhibiting major responses.[14] However, the recently reported results of a phase III trial comparing cisplatin/IL-2/temozolomide vs cisplatin/IL-2/dacarbazine did not show any benefit of temozolomide in preventing brain metastases.[15]
Hence, temozolomide has not proven to be superior to dacarbazine. The choice between the two drugs is usually guided by the desired route of administration, cost differences, and the presence or absence of brain metastases.
• Antimicrotubular Agents—Vinca alkaloids (inhibitors of microtubular assembly) such as vindesine and vinblastine, and taxanes (inhibitors of microtubule disassembly) such as paclitaxel have modest single-agent activity in patients with metastatic melanoma.[16,17] Vinblastine has been incorporated in various combination chemotherapy and biochemotherapy regimens. Paclitaxel, used as a single agent or in combination with other agents, has antitumor activity (ORR = 16%–26%) in patients with metastatic melanoma, including patients whose disease has progressed on prior chemotherapies.[17-19] Weekly administration of paclitaxel at a dose of 80 to 100 mg/m2 (on days 1, 8, and 15 every 4 weeks) is well tolerated by most patients. Alternatively, a higher dose can be administered once every 3 to 4 weeks.
Associated toxicities include fatigue, alopecia, myelosuppression, neuropathy, myalgias, and hypersensitivity reactions. An albumin-bound, nanoparticle form of paclitaxel (ABI-007, or Abraxane) had an ORR of 27% in 34 chemotherapy-naive patients with metastatic melanoma in a phase II trial.[20]
• Platinum Analogs—Cisplatin and carboplatin have modest activity in patients with metastatic melanoma. Single-agent cisplatin given at conventional doses yields a response rate of less than 10%. However, a phase II study that used a higher dose (150 mg/m2) of cisplatin in combination with amifostine reported an ORR of 53%, although the responses were short-lived.[21] A response rate of 19% was observed with carboplatin in a phase II study in chemotherapynaive patients with metastatic melanoma.[22] Carboplatin has also been used in combination with paclitaxel in previously treated patients.[19]
• Nitrosoureas—Nitrosoureas such as carmustine (BCNU), lomustine (CCNU), and fotemustine have single-agent activity comparable to dacarbazine, although they cause more myelosuppression and alopecia. Fotemustine rapidly crosses the blood-brain barrier and has been found to have encouraging activity in patients with brain metastases.[23] When compared to dacarbazine in a phase III trial involving 229 patients with metastatic melanoma, fotemustine was associated with a higher ORR (15% vs 7%, respectively) and a trend toward improved survival (7.3 vs 5.6 months, respectively).[24] In patients without brain metastases at inclusion, the median time to development of brain metastases was 22.7 months in the fotemustine arm vs 7.2 months in the dacarbazine arm. Fotemustine has not been approved by the FDA but is available in Europe.
Combination Chemotherapy
The modest antitumor activity of the chemotherapeutic agents mentioned above led to investigation of combinations of these agents to improve outcomes. Single-institution studies suggested that combination chemotherapy might lead to an increase in the response rate and possibly survival.
The combination of cisplatin, dacarbazine, BCNU, and tamoxifen (CDBT), also known as the Dartmouth regimen, was initially reported to have an ORR of 55%.[25,26] However, a phase III multicenter trial that randomized 240 patients to the CDBT regimen vs dacarbazine monotherapy did not show a statistically significant benefit in favor of the combination.[27] Despite a modest difference in ORR in favor of CDBT over dacarbazine (16.8% and 9.9%, respectively; P = .13), there was no significant difference in OS (7.7 and 6.3 months, respectively; P = .52). Myelosuppression, fatigue, nausea, and vomiting were significantly higher in the CDBT arm.
Another combination that includes cisplatin, vinblastine, and dacarbazine (CVD), had an ORR of 40% in a phase II study.[28] The CVD regimen was later used as a backbone for combining with IL-2 and interferon to develop biochemotherapy regimens.[29]
The combination of paclitaxel and carboplatin (PC) has been reported to have antitumor activity in patients with metastatic melanoma, including patients who have received prior chemotherapy.[ 19,30] The PC regimen was recently used as the comparator arm in two randomized, placebocontrolled, phase III trials testing PC vs PC plus sorafenib (Nexavar). In one of these trials involving patients who had received prior dacarbazine or temozolomide, patients who received PC alone had an ORR of 11%, median PFS of 17.9 weeks, and median OS of 42 weeks.[31]
In summary, combinations of cytotoxic agents may yield somewhat higher response rates than dacarbazine monotherapy, but are associated with greater toxicity and do not extend survival significantly.
1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008.
2. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001.
3. Barth A, Wanek LA, Morton DL: Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 181:193- 201, 1995. .
4. Eton O, Legha SS, Moon TE, et al: Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 16:1103-1111, 1998.
5. Keilholz U, Conradt C, Legha SS, et al: Results of interleukin-2-based treatment in advanced melanoma: A case record-based analysis of 631 patients. J Clin Oncol 16:2921- 2929, 1998 .
6. Manola J, Atkins M, Ibrahim J, et al: Prognostic factors in metastatic melanoma: A pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 18:3782-3793, 2000.
7. Schmidt H, Suciu S, Punt CJ, et al: Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: Results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 25:1562-1569, 2007.
8. Wong JH, Skinner KA, Kim KA, et al: The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery 113:389-394, 1993.
9. Fletcher WS, Pommier RF, Lum S, et al: Surgical treatment of metastatic melanoma. Am J Surg 175:413-417, 1998.
10. Lui P, Cashin R, Machado M, et al: Treatments for metastatic melanoma: Synthesis of evidence from randomized trials. Cancer Treat Rev 33:665-680, 2007..
11. Hill GJ 2nd, Krementz ET, Hill HZ: Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A). Cancer 53:1299- 1305, 1984.
12. Middleton MR, Grob JJ, Aaronson N, et al: Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 18:158-166, 2000.
13. Patel P, Suciu S, Mortier L, et al: Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV malignant melanoma: Final results of the randomised phase III study EORTC 18032 (abstract LBA8). Stockholm, 33rd European Society of Medical Oncology (ESMO) Congress, 2008.
14. Quirt I, Verma S, Petrella T, et al: Temozolomide for the treatment of metastatic melanoma: A systematic review. Oncologist 12:1114-1123, 2007.
15. Chiarion-Sileni V, Guida M, Ridolfi R, et al: Temozolomide (TMZ) as prophylaxis for melanoma brain metastases (BrM): Results from a phase III, multicenter study (abstract 20014). J Clin Oncol 26(15S):723s, 2008.
16. Quagliana JM, Stephens RL, Baker LH, et al: Vindesine in patients with metastatic malignant melanoma: A Southwest Oncology Group study. J Clin Oncol 2:316-319, 1984.
17. Wiernik PH, Einzig AI: Taxol in malignant melanoma. J Natl Cancer Inst Monogr (15):185-187, 1993.
18. Nathan FE, Berd D, Sato T, et al: Paclitaxel and tamoxifen: An active regimen for patients with metastatic melanoma. Cancer 88:79-87, 2000.
19. Rao RD, Holtan SG, Ingle JN, et al: Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma. Cancer 106:375-382, 2006.
20. Hersh EM, O'Day S, Gonzalez R, et al: Multicenter phase II study of ABI-007 (Abraxane) in previously treated and chemotherapy naïve patients with metastatic malignant melanoma (MMM) (abstract 27). Proceedings of the 23rd Annual Chemotherapy Foundation Symposium, New York, 2005.
21. Glover D, Glick JH, Weiler C, et al: WR- 2721 and high-dose cisplatin: An active combination in the treatment of metastatic melanoma. J Clin Oncol 5:574-578, 1987.
22. Evans LM, Casper ES, Rosenbluth R: Phase II trial of carboplatin in advanced malignant melanoma. Cancer Treat Rep 71:171- 172, 1987.
23. Khayat D, Giroux B, Berille J, et al: Fotemustine in the treatment of brain primary tumors and metastases. Cancer Invest 12:414- 420, 1994.
24. Avril MF, Aamdal S, Grob JJ, et al: Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: A phase III study. J Clin Oncol 22:1118-1125, 2004.
25. Del Prete SA, Maurer LH, O'Donnell J, et al: Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 68:1403-1405, 1984.
26. Lattanzi SC, Tosteson T, Chertoff J, et al: Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res 5:365-369, 1995.
27. Chapman PB, Einhorn LH, Meyers ML, et al: Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 17:2745-2751, 1999.
28. Legha SS, Ring S, Papadopoulos N, et al: A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer 64:2024-2029, 1989.
29. Legha SS, Ring S, Bedikian A, et al: Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann Oncol 7:827-835, 1996.
30. Hodi FS, Soiffer RJ, Clark J, et al: Phase II study of paclitaxel and carboplatin for malignant melanoma. Am J Clin Oncol 25:283- 286, 2002.
31. Agarwala SS, Keilholz U, Hogg D, et al: Randomized phase III study of paclitaxel plus carboplatin with or without sorafenib as second-line treatment in patients with advanced melanoma (abstract 8510). J Clin Oncol 25(18S):474s, 2007.
32. Atkins MB, Kunkel L, Sznol M, et al: High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update. Cancer J Sci Am 6(suppl 1): S11-S14, 2000.
33. Atkins MB, Lotze MT, Dutcher JP, et al: High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105-2116, 1999.
34. Smith FO, Downey SG, Klapper JA, et al: Treatment of metastatic melanoma using interleukin- 2 alone or in conjunction with vaccines. Clin Cancer Res 14:5610-5618, 2008.
35. Creagan ET, Ahmann DL, Frytak S, et al: Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: Results in 96 patients. Cancer Treat Rep 70:619- 624, 1986.
36. Dummer R, Garbe C, Thompson JA, et al: Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma. J Clin Oncol 24:1188- 1194, 2006.
37. Thomson DB, Adena M, McLeod GR, et al: Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial. Melanoma Res 3:133-138, 1993.
38. Bajetta E, Di Leo A, Zampino MG, et al: Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol 12:806-811, 1994.
39. Falkson CI, Ibrahim J, Kirkwood JM, et al: Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group study. J Clin Oncol 16:1743-1751, 1998.
40. Rosenberg SA, Yang JC, Schwartzentruber DJ, et al: Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin- 2 and interferon alfa-2b. J Clin Oncol 17:968-975, 1999.
41. Eton O, Legha SS, Bedikian AY, et al: Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial. J Clin Oncol 20:2045-2052, 2002.
42. Ridolfi R, Chiarion-Sileni V, Guida M, et al: Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: Results from an Italian multicenter phase III randomized clinical trial. J Clin Oncol 20:1600- 1607, 2002.
43. Kaufmann R, Spieth K, Leiter U, et al: Temozolomide in combination with interferonalfa versus temozolomide alone in patients with advanced metastatic melanoma: A randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. J Clin Oncol 23:9001-9007, 2005.
44. Bajetta E, Del Vecchio M, Nova P, et al: Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin- 2 and interferon-alpha2b in metastatic melanoma. Ann Oncol 17:571-577, 2006.
45. Atkins MB, Hsu J, Lee S, et al: Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin- 2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): A trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 26:5748-5754, 2008.
46. Ives NJ, Stowe RL, Lorigan P, et al: Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: A metaanalysis of 18 trials involving 2,621 patients. J Clin Oncol 25:5426-5434, 2007.
47. Tarhini AA, Kirkwood JM, Gooding WE, et al: Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. J Clin Oncol 25:3802-3807, 2007.
48. Miller AJ, Mihm MC Jr: Melanoma. N Engl J Med 355:51-65, 2006.
49. Ribas A, Hauschild A, Kefford R, et al: Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206) and chemotherapy (temozolomide [TMZ] or dacarbazine [DTIC]) in patients with advanced melanoma (abstract LBA9011). J Clin Oncol 26(15S):485s, 2008.
50. Downey SG, Klapper JA, Smith FO, et al: Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res 13(22 pt 1):6681-6688, 2007.
51. Bedikian AY, Millward M, Pehamberger H, et al: Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The Oblimersen Melanoma Study Group. J Clin Oncol 24:4738-4745, 2006.
52. McDermott DF, Sosman JA, Gonzalez R, et al: Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: A report from the 11715 Study Group. J Clin Oncol 26:2178-2185, 2008.
53. O'Day S, Gonzalez R, Lawson D, et al: Subgroup analysis of efficacy and safety analysis of a randomized, double-blinded controlled phase II study of STA-4783 in combination with paclitaxel in patients with metastatic melanoma (abstract 8528). J Clin Oncol 25(18S):479s, 2007.
54. Dudley ME, Yang JC, Sherry R, et al: Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 26:5233-5239, 2008.
55. Hunder NN, Wallen H, Cao J, et al: Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 358:2698-2703, 2008.
56. Richards JM, Bedikian AY, Gonzalez R, et al: High-dose Allovectin-7R in patients with advanced metastatic melanoma: Final phase 2 data and design of phase 3 registration trial (abstract 7543). J Clin Oncol 23(16S):720s, 2005.


text:
Saturday, September 8, 2007
The embarrassment was the fans that booed the team off the field at halftime, and at other times as well. It was loud and clear on my television from 2,500 miles away, so I am certain that it was several orders of magnitude louder inside the stadium. I know not all of you did, but to the ones that did, you are a fucking embarrassment to the University of Georgia, and if you are going to boo 18-22 year old kids, then please stay home. And don't come with that weak shit "I was just booing the coaching staff, or the playcalling. Not the kids." Fuck you for thinking that anyone could selectively distinguish the narrow and specific philosophical nature of your booing. If this was the first time this has happened then I wouldn't be so pissed about it. But it's not. I remember writing about it at least 2 times last year, and can remember other instances of it beyond that. Shit Terrance Edwards was what, six, seven years ago? To repeatedly do this is a totally embarrassing representation of our fanbase and school.
If I was a recruit at one of the games when this happened, then I would have serious, serious reservations about committing my future to UGA. When things are down the team need you to be as encouraging as ever, and we have all seen that crowds can be a motivational 12th man. When things are shit, in sports or in life, it's positive encouragement and belief in you from others that spur you out of it and onto better things, not turncoat negativity and abandonment. What the team needed was an encouraging and rousing standing ovation from all 83,000 UGA fans that said "Come on! We're behind you and we believe in you! We both know that you have fucked up and can do much better, so let's do just that- you can do this! "
Moan. Groan. Throw shit. Break something. Curse like a motherfucking sailor at that God damn shitty playcall on 4th and 2 or the missed tackles or the poor throws or the drops and on and on. Whatever. But do not give up and turn on your team when things are not going well. It is a horrible and insulting message to send to the young men who represent our school, and it speaks volumes to your level of so-called fandom. You are a fairweather bandwagoner who only cheers for a winner, and I do not appreciate you. You are chickenshits.
If you are a true fan of UGA, or any other team for that matter, then root for, cheer, and encourage that team when things are going great and when things are going shitty. In fact, the more you stand by your team when they perform poorly, the more you show yourself to be a real fan of the team.
The next time something shitty happens in your life, or you completely fuck up, be it relationship, job, or otherwise related, and you are down and out, and a friend or family member gives you positive words of encouragement that makes you feel better, believe in yourself, and helps you get out of the bad situation and out of the rain and back in to the sunshine, and you think about how much you appreciate that person and their words which were so helpful, think about how you would have felt if instead of offering words of encouragement and support, those same people booed you and told you that you were shit when you needed a boost. Then think about the fact that, as an alleged diehard loyal Bulldog, you booed the shit out of 20 year old kids when things weren't going well but there was still all to play for, and what a shitbird wanker that makes you look like.
And triple everything I just said for anyone who is an alumnus of the University Of Georgia and not just a "fan" in general.
If you want to see how it should be done, then check out Portsmouth of the EPL sometime. Down 0-4 after 35 minutes at home to an absolutely rampant Arsenal in an FA Cup match back in 2003, they sang in support of their team, 28,000 strong at the top of their lungs, for the entire 90 minutes en route to an absolute 5-1 assbeating. It was completely astounding and beyond impressive to anyone who witnessed it, and was commented on far and wide, even by the Arsenal players and manager. Their fans are widely regarded as the best in the land for just this reason, and are respected far and wide even though they are not a great team.
15 comments:
- Crews said...
incredibly on point.
- Sunday, September 9, 2007 at 11:06:00 AM PDT
- Aureliano said...
Well said. I was at the stadium. Heard it too, although louder at times last year and before.
What was missed (probably) through your tv set was the lack of enthusiasm from our crowd. We were much much louder against Oklahoma State. Not a lot of screaming from our fans on big plays when they needed us on defense, even in the 4th quarter. Seriously in my section I was the only one up and screaming on a lot of those third down plays at the end of the game. That, to me, is embarrassing. I've put up with fan support like that when we play teams like Georgia Southern at noon...but this was essentially a night SEC East matchup. Our student section seemed into it, but the rest of the crowd I guess pretty much just assumed we'd walk away with a win in the game or something. sigh.
- Sunday, September 9, 2007 at 5:18:00 PM PDT
That's UGA for ya. *Pound the body and the head will fall, work it!*
I don't like booing for bad performances, but certain times it is justified. Like when a guy obviously can't be bothered and isn't even trying. After a particularly egregious display of such, it is acceptable to me to boo the sucker. But booing just for a general-not-so-goodness is uncalled for.
- Sunday, September 9, 2007 at 5:55:00 PM PDT
- Kanu said...
Crews- gracias.
Aureliano- that is classic UGA. The crowd gets loud and crazy for a big game when they think we might very well lose, or we're playing a team that is perceived to be better than us, but when our fanbase decides that we most likely should win a game, they are much more passive as you pointed out. Example 1: Okie State and then USC. There are a million examples of this. Another longstandinig pattern related to this and fan expectation level is following a huge win by everyone talking about how great we are and then expecting an easier win against the next opponent, which results in what you talked about on the part of the fans, and also the team seems to sometimes read the press clippings after a huge and impressive win and come out not as focused and thinking that all they have to do it show up and they will probably win. OK State/S. Car 07, 2005 SEC Champ. Game/West Virginia, 2004 LSU blowout/home loss to Tennessee, 1997 massive upset of Florida then get dominated by Auburn at home are four of several examples of this that come immediately to mind.
Except when we play Wisconsin or Clemson, then we seem to do just fine ;)
I agree with your point, but only for professional sports. For some reason I see it entirely differently when you are dealing with professional athletes who are paid, and paid ridiculously well, to play a game, especially when as you say they sometimes clearly go through the motions, half-ass it, and pick up ginormous paychecks {read: 75% of the NBA}. But to boo college kids is complete chickenshit and totally uncalled for. First and foremost, Sat night {and most other past instances with UGA fans} it's not a matter of a lack of effort but rather a lack of execution, so that rules out what we have agreed upon. Second, they are college kids who are not paid and who sacrifice a lot of time and energy and effort, and in the end they are giving it the old college try. And the argument that they are just minor league pros, that they all go pro anyways, and that they are being paid in a scholarship is rubbish too. Only a select few will ever cash a check playing football: overall in CFB the numbers are 1% that make it to the NFL, at an elite D1 school like UGA maybe 10% {that would be saying that of the 85 dudes on the team right now, 8-9 will go on to play in the NFL, which seems about right}. So between 90-99% of the kids are not "just like pros" etc, etc.
Not a rant directed towards you at all, just clarifying my position/original rant with regard to booing college athletes vs. booing pros. Booing pros is still a bit weak, but I can see circumstances where I have no problem with it.
- Monday, September 10, 2007 at 11:58:00 AM PDT
- beast in 'bama said...
I agree 100%. If you don't agree with the coaching or the play calling, let yourself be heard AFTER the game in a more appropriate venue. Booing inside the stadium - during or after the game - is not appropriate for college athletics.
That was one bloody-knuckled street fight, as all USC/UGA games seem to be. I wouldn't get too down about it. USC's defense is legit, and you've got to figure the SEC East is going to cannibalize itself this season. Win the games you're supposed to and find a way to get over the Florida hump and you're right back in the race.
One glaring problem I noticed with Stafford's technique - he drifts his feet around and leans his upper body back while throwing. His arm is terrific, but he doesn't always set his feet and get into the throw. As a result he tends to spray the ball around more than you'd like. I noticed this against Okie light last week, but he got away with it. It's a totally correctable flaw, but one that could cost him a pick or two down the road.
- Monday, September 10, 2007 at 1:28:00 PM PDT
I got no arguments over what you say at all. There is a clear distinction between getting paid to do something and still half-assing it and what happens in college. The booing at the game you are referring to is unwarranted, I agree.
And I can't really say anything about UGA/Clemson, since you guys own us about as badly as we own USC.
Don't know about Wisconsin though, have the 2 schools ever played each other?
- Monday, September 10, 2007 at 2:48:00 PM PDT
- Kanu said...
I was just clowning around, but yes, twice that I know of:
1998 Outback Bowl: Georgia 33-6 Wisconsin. Ron Dayne 14 carries for 36 yards.
2005 Outback Bowl: Georgia 24-21 Wisconsin
- Monday, September 10, 2007 at 3:08:00 PM PDT
Maybe I blocked out that 2005 game on purpose.
- Monday, September 10, 2007 at 5:05:00 PM PDT
- LD said...
I haven't watched the game on TV, so I don't know what was audible there...
But I do sit in the stadium, and directly next to the largest congregation of recruits (I sit in 325, row 18 and most of the recruits are in 326, above row 20). And I don't really know what you're talking about in terms of booing.
At the end of the first half, I heard booing, but it was after the entire Georgia team had left the field. The booing was coming from the student section in the lower level, northeast corner. The only individual involved in the actual, on-field competition that was still out on the field was Steve O. Spurrier, just finishing his halftime interview. The booing around halftime was directed, and only could've been directed, at Coach Spurrier.
Now, in the abstract, I agree totally that booing college kids is wrong.
But for practical purposes, I don't know how one can control grumbling at the end of the game.
And there's another practical thing. Halftime booing of your own team is bullshit, but I don't know if it has the effect that most of us fear the most. Sitting where I sit (and it's been this way for 4 straight years), I've seen how recruits act at games. Here's what it's like: they get to their seats way late. Like, mid-first quarter. They spend very little time watching the game. Most of the time is spent talking to Georgia Girls or running up and down the aisles getting cokes and pretzels and stuff. Trust me, I notice this because a lot of these guys are very big and frequently block my view of the game at inopportune times. Then, with about 5 minutes to go before halftime, the entire section empties out because the recruits and their coaches/friends/chaperones and the accompanying Georgia Girls leave their seats to go to a reception room where the players get food and drinks and can meet with some other athletic department people. Then, usually in the middle of the third quarter, the recruits return... maybe. More than half the section typically doesn't come back after halftime, especially during a late game.
Conceptually, it can be bad in terms of recruiting, that some fans boo. IN practice though, I question whether many of the recruits actually hear it. I'd bet they're more likely to hear about it via message boards and news reports than in the stadium.
And also, seriously. The halftime booing was directed at Spurrier. Everyone else was already in the locker room when the booing started.
- Monday, September 10, 2007 at 7:39:00 PM PDT
- Kanu said...
Thanks for your perspective/input LD. Mucho appreciado mi amigo {sorry, just got back from Spanish class...}
On TV, for me anyways, it came across as our fans booing our team as they ran off the field and into the locker room, and it being pretty loud before the ESPN cameras kicked it down to {insert marginally hot stupid question asking female sideline reporter here} for her interview with J.R. Ewing, so thanks a bunch for your account.
If it was the 1st time, or if we were losing 31-3 then it probably wouldn't have struck me the way it did, but by all accounts there were incidents of booing the team last season as well and at halftime we still had everything to play for.
Either way, every fanbase has exemplary fans and shitbird fans, and everything in between. I was really frustrated and pissed about watching that loss unfold for 3 hours, and immediately after the game that manifested itself in this rant post about the booing. 2 days on and I'm in a much more Zen like place about the loss, and also about getting so worked up about this as well.
You said it best man "Flush The Turd. Let's Get Better". That seriously should be on T-shirts, it's way more profound than "Finish The Drill" or "TEAM me"
Shit, the two dudes who started the "Life Is Good" brand with the stick figure drawings began by selling "Life Is Good" T- shirts out of their garage, and today they are each multimillionaires. Something to think about LD...
- Monday, September 10, 2007 at 11:20:00 PM PDT
- LD said...
My brother wrote that, after going to the game, returning home and re-watching it two more times before sleeping on Saturday night. Same kind of response.
As for the booing, it goes back to the Auburn game in, I think, 1999. It was an embarrassment then, and remains one every time it happens. I'm sure there were some morons booing the team (or coaches or whoever), but I really think the vast majority of the halftime booing was directed at Spurrier. I don't want to be unequivocal, but that's honestly how I saw it. Now, at the end of the game, I know there was more booing (and there was some booing after the 4th and 2 playfake sack, and that I think was very clearly directed at the OC box). None of that was acceptable, but it happens. Fans are emotionally tied to the game, probably too much so. I know I am.
- Tuesday, September 11, 2007 at 5:38:00 AM PDT
While I completely agree with your sentiments regarding college players, namely, there is no place for it, sitting in section 323, I didn't get the impression that the boos were for the team. Most of the booing I heard seemed to be clearly directed at the refs.
As to the halftime booing, I confess I was with my daughter out in the concourse, so I didn't hear that. But generally, UGA fans haven't booed the team in a while. AU 1999 was the last time I recall it being really bad. But I agree, it would be nice if we cheered harder when the team was down.
- Tuesday, September 11, 2007 at 7:36:00 AM PDT
- Kanu said...
We're squarely into dead horse territory now, but it was an interesting coincidence that last last night after reading your comment & responding, I happened to switch on the TV on before bed and they were replaying the game on ESPN2, and there were 2 min left in the 1H. So I watched to get a 2nd viewing, and there definitely is loud booing as the team begins to walk off the field.
You were there, I'm not telling you that you were wrong, it was just interesting the way it cam across in the TV presentation- the way the shots were. hell, it could be that in the stadium they flashed Spurrier on the jumbotron and everyone booed, while ESPN has a the panned back shot of the team starting to walk off the field.
Either way it doesn't really matter, everyone seems to agree that booing college players is chickenshit and wrong, and that is the main thing I was trying to get across.
OK, horse officially dead now. Time to move on.
- Tuesday, September 11, 2007 at 11:34:00 AM PDT
Wow, who wants horsemeat carpaccio?
Concur on the UGA booing - I watched the game without volume for the majority but hate to hear a reminder of Terrence Edwards or like events in Dawg history. I have been to way too many games in Jacksonville to condone any booing of the boys in the Silver Britches 'tween the hedges...and I know game day pain.
- Tuesday, September 11, 2007 at 8:10:00 PM PDT
Im going to have to agree with ID - No one was booing the UGA team in any shape or form. The crowd may not have been as loud as for OK state - hard to repeat that performance - but they were into it until the INT was thrown with 20 or so seconds left. The only booing going on was for Steve F'in Spurrier, who, if you are a real dawgs fan, should be booed at every and any opportunity.
- Wednesday, September 12, 2007 at 6:48:00 AM PDT


text:
Lone Colac ambulance risks patients' lives: union
LIVES in Colac and district will be put at risk if only one ambulance is left to respond to emergencies overnight, health unions warn.
The Ambulance Employees Association (AEA) and the Australian Nurses Federation (ANF) have both warned that the decision to leave all emergencies in Colac to a single ambulance crew each night could result in patients dying while waiting for paramedics. Plans by Colac Area Health (CAH) to close its urgent care unit overnight will mean all emergency cases will be transferred to Geelong — leaving Colac without an ambulance for up to three hours.
The public will get updates next Tuesday from CAH, Ambulance Victoria and Victoria Police at an information session at the Colac Otway Performing Arts and Cultural Centre at 7pm.
But the Victorian head of the AEA, which represents the paramedics, told The Standard ambulance crews in Colac feared critical delays.
"Unless additional resources are put in place, lives will be put at risk," AEA secretary Steve McGhie said.
"There's only one ambulance in Colac at that time. The next closest ambulance could come from Geelong or Camperdown, who knows? It would take the best part of an hour to respond to Colac."
Mr McGhie said crews in Geelong were already overburdened and unlikely to respond to incidents in Colac. He said the threat remained that crews in Camperdown and Lorne could be busy if needed.
"They need to at least put another night shift on in Colac," he said.
"The ideal situation is that Colac doesn't close its accident and emergency department.
"It's a real problem and it's putting the public at risk."
Ambulance Victoria was tight-lipped this week when asked how it would respond to the new requirements, but hinted at extra resources being moved into the district.
The ANF also weighed in to the debate, this week sharing the unease of paramedics.
ANF state secretary Lisa Fitzpatrick said it was up to the Victorian government to fix the funding shortfall at Colac Hospital.
"If the one ambulance in Colac is already on a transfer, a critically ill person would be expected to wait for an ambulance from Geelong or even Warrnambool," Ms Fitzpatrick said.
She said Colac Hospital had also closed six beds this week.
Member for Corangamite Darren Cheeseman yesterday used his Twitter account to warn that Warrnambool ambulances could be drawn to Colac.
But Mr McGhie said it was unlikely Warrnambool would send paramedics an hour-and-a-half to emergencies in the Colac area.
Discuss "Lone Colac ambulance risks patients' lives: union"
Please note: All comments made or shown here are bound by the Online Discussion Terms & Conditions.


text:
GE Global Research, the centralized research organization of General Electric, and GE Consumer & Industrial, recently announced the successful demonstration of the world's first roll-to-roll manufactured organic light-emitting diode (OLED) lighting devices. According to the company, this demonstration is a key step toward making OLEDs and other high performance organic electronics products at dramatically lower costs than what is possible today.
"Researchers have long dreamed of making OLEDs using a newspaper-printing like roll-to-roll process," says Anil Duggal, manager of GE's Advanced Technology Program in Organic Electronics. "Now we've shown that it is possible. Commercial applications in lighting require low manufacturing costs, and this demonstration is a major milestone on our way to developing low cost OLED lighting devices."


text: Welcome to the AMEC Members Area. Every document available here has been produced to help members better understand their benefits in order to receive the maximum value from their membership. AMEC also produces a newsletter providing information and updates about its services for its members. If you would like to be added to the mailing list please contact firstname.lastname@example.com.


text:
Some Girl Gets Arrested For A Skimpy Prom Dress In Texas!
CBS Reports: "Marche Taylor was taken away in handcufss because her dress violated the school's dress code.
Please click the "Report" button below if the video on this page is not working properly.
Comments will only be displayed by verified emails. No Spamming or Racism.


text:
Journal for Eighteenth-Century Studies
Journal for Eighteenth-Century Studies
Vol 40(4 Issues in 2017 ) Print ISSN: 1754-0194 Online ISSN: 1754-0208
Download Product Flyer
The Journal for Eighteenth-Century Studies (JECS) acts as a meeting-place for the many academic disciplines that make up a period study: among others History, Literature, Science, Economics, Fine Art, Music, Religion, Geography and Popular Culture. Special notice is taken of research that explores links between the disciplines, and which helps to develop cross-disciplinary fields of enquiry. Significant and original research taking any methodological approach – from the heavily historicised and data-driven to the theoretically-informed – is all equally valued.
JECS seeks to publish the best research on the long eighteenth-century (circa 1675-1825) irrespective of which parts of the world this research concerns. While most of the articles appearing since its launch (as the British Journal for Eighteenth-Century Studies) in 1978 have focused on Western Europe and North America, new research on the eighteenth century beyond those borders, and on the interconnected 'global eighteenth century', is now particularly welcome.
Articles submitted for publication in JECS are assessed by a rigorous and anonymised process of double peer review, and competition for inclusion is fierce. JECS accepts only papers which move one or more academic disciplines forward, and strives to publish the finest scholarship regardless of the status of the submitting author. Alongside its articles, JECS publishes reviews of the most notable recent work on eighteenth-century topics across a wide range of disciplines. Reviews of events, exhibitions, concerts, films and so on, likely to be of interest to readers of JECS, are to be found on the website of the British Society for Eighteenth-Century Studies: http://www.bsecs.org.uk.